Radiotherapy or chemoradiotherapy for postoperative locoregional recurrence of non-small cell lung cancer

Kei Shibuya; J. Saito; T. Kazumoto; Y. Saito; H. Nishimura; H. Akiyama; S. Kato

Radiotherapy or chemoradiotherapy for postoperative locoregional recurrence of non-small cell lung cancer

Kei Shibuya^*, J. Saito, T. Kazumoto, Y. Saito, H. Nishimura, H. Akiyama, S. Kato

^*この論文の責任著者

放射線診断・治療学講座

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

抄録

Twenty-two patients with locoregional recurrent non-small cell lung cancer after surgical resection. RT doses that ranged from 50 to 67 Gy were delivered. Chemotherapy was performed concurrently in twelve patients. The overall 2-year and 3-year survival rates after treatment for recurrences were 46% and 31%. The median survival time was 15.6 months. No severe acute and late toxicity was observed. In conclusion, radiotherapy or chemoradiationtherapy for postsurgical locoregional recurrences is an effective and safe treatment modality.

本文言語	英語
ページ（範囲）	182-187
ページ数	6
ジャーナル	Japanese Journal of Clinical Radiology
巻	54
号	1
出版ステータス	出版済み - 2009

ASJC Scopus 主題領域

放射線学、核医学およびイメージング

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

引用スタイル

@article{59b91dcba88d44bca823b8c01bd7d790,

title = "Radiotherapy or chemoradiotherapy for postoperative locoregional recurrence of non-small cell lung cancer",

abstract = "Twenty-two patients with locoregional recurrent non-small cell lung cancer after surgical resection. RT doses that ranged from 50 to 67 Gy were delivered. Chemotherapy was performed concurrently in twelve patients. The overall 2-year and 3-year survival rates after treatment for recurrences were 46% and 31%. The median survival time was 15.6 months. No severe acute and late toxicity was observed. In conclusion, radiotherapy or chemoradiationtherapy for postsurgical locoregional recurrences is an effective and safe treatment modality.",

author = "Kei Shibuya and J. Saito and T. Kazumoto and Y. Saito and H. Nishimura and H. Akiyama and S. Kato",

year = "2009",

language = "英語",

volume = "54",

pages = "182--187",

journal = "Japanese Journal of Clinical Radiology",

issn = "0009-9252",

publisher = "Kanehara Shuppan Co. Ltd",

number = "1",

}

TY - JOUR

T1 - Radiotherapy or chemoradiotherapy for postoperative locoregional recurrence of non-small cell lung cancer

AU - Shibuya, Kei

AU - Saito, J.

AU - Kazumoto, T.

AU - Saito, Y.

AU - Nishimura, H.

AU - Akiyama, H.

AU - Kato, S.

PY - 2009

Y1 - 2009

N2 - Twenty-two patients with locoregional recurrent non-small cell lung cancer after surgical resection. RT doses that ranged from 50 to 67 Gy were delivered. Chemotherapy was performed concurrently in twelve patients. The overall 2-year and 3-year survival rates after treatment for recurrences were 46% and 31%. The median survival time was 15.6 months. No severe acute and late toxicity was observed. In conclusion, radiotherapy or chemoradiationtherapy for postsurgical locoregional recurrences is an effective and safe treatment modality.

AB - Twenty-two patients with locoregional recurrent non-small cell lung cancer after surgical resection. RT doses that ranged from 50 to 67 Gy were delivered. Chemotherapy was performed concurrently in twelve patients. The overall 2-year and 3-year survival rates after treatment for recurrences were 46% and 31%. The median survival time was 15.6 months. No severe acute and late toxicity was observed. In conclusion, radiotherapy or chemoradiationtherapy for postsurgical locoregional recurrences is an effective and safe treatment modality.

UR - http://www.scopus.com/inward/record.url?scp=59249100348&partnerID=8YFLogxK

M3 - 学術論文

AN - SCOPUS:59249100348

SN - 0009-9252

VL - 54

SP - 182

EP - 187

JO - Japanese Journal of Clinical Radiology

JF - Japanese Journal of Clinical Radiology

IS - 1

ER -

Radiotherapy or chemoradiotherapy for postoperative locoregional recurrence of non-small cell lung cancer

抄録

ASJC Scopus 主題領域

UN SDG

フィンガープリント

引用スタイル